long-term treatment with timolol in patients ages 65 -- 75 years who survived myocardial infarction was related to a significant reduction , compared with placebo , in overall mortality ( p less than 0.05 ) , total cardiac death ( p less than 0.01 ) , sudden death ( p less than 0.05 ) and reinfarction ( p less than 0.01 ) .
C0040233
timolol
C0027051
myocardial infarction